当前位置:
X-MOL 学术
›
Nat. Rev. Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The artificial pancreas in 2017: The year of transition from research to clinical practice
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2017-12-22 , DOI: 10.1038/nrendo.2017.170 Boris Kovatchev
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2017-12-22 , DOI: 10.1038/nrendo.2017.170 Boris Kovatchev
The artificial pancreas in 2017: The year of transition from research to clinical practice
中文翻译:
2017年的人造胰腺:从研究到临床实践的过渡年
2017年的人造胰腺:从研究到临床实践的过渡年
更新日期:2017-12-22
The artificial pancreas in 2017: The year of transition from research to clinical practice, Published online: 22 December 2017; doi:10.1038/nrendo.2017.170
The artificial pancreas — the automated closed-loop control of diabetes mellitus — made its first outpatient strides in 2011. In 2017, the results of long-term clinical trials on the artificial pancreas were published, the first hybrid commercial artificial pancreas system was approved and the artificial pancreas was tested under increasingly demanding conditions. Thus, artificial pancreas technology is here to stay.中文翻译:
2017年的人造胰腺:从研究到临床实践的过渡年
2017年的人造胰腺:从研究到临床实践的过渡年
2017年的人工胰腺:从研究到临床实践的过渡年,在线发布:2017年12月22日; 2017年。doi:10.1038 / nrendo.2017.170
人造胰腺-糖尿病的自动闭环控制-于2011年实现了首例门诊。2017年,发表了人造胰腺的长期临床试验结果,第一个混合商用人造胰腺系统得到批准并获批。在越来越严格的条件下对人造胰腺进行了测试。因此,人造胰腺技术将继续存在。